The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial results: https://nej.md/3MBP1uc | The New England Journal of Medicine
1:56
The SCALE Kids trial, summarized here by NEJM Editorial Fellow Harleen Marwah, MD, assessed the efficacy and safety of liraglutide, as compared with placebo, as an adjunct treatment to lifestyle interventions, for the treatment of obesity in children 6 to 12 years of age. Full trial results: https://nej.md/3MBP1uc | The New England Journal of Medicine
FacebookThe New England Journal of Medicine4.4K viewsMar 15, 2025
See more
Static thumbnail place holder
You may also want to search